Immune Cell Therapy's Other Investors

Immune Cell Therapy raised a round of funding on , . Investors include Capital Midwest Fund.

ICT is developing a personalized vaccine treatment to help cancer from recurring. A small amount of the patient's own primary tumor is used to prepare the vaccine, so that the vaccine targets the spec…

Articles about Immune Cell Therapy's Other Investors: